Mixed
Bariatric surgery (specifically Sleeve Gastrectomy and Roux-en-Y Gastric Bypass) produces significant, sustained weight loss and metabolic improvements in adults with morbid obesity, with RYGB generally demonstrating superior long-term weight loss and diabetes remission rates compared to SG.
For individuals with a BMI ≥35 (or ≥30 with comorbidities like diabetes), bariatric surgery is the most effective medical intervention for significant, sustained weight loss and metabolic health improvement. Roux-en-Y Gastric Bypass (RYGB) generally offers better long-term weight loss and diabetes remission than Sleeve Gastrectomy (SG), but requires strict lifelong supplementation and monitoring. Surgery is not a first-line option for mild obesity but is critical for morbid obesity where lifestyle changes fail.
Bariatric surgery is the most effective treatment modality for obesity, leading to significant weight loss and metabolic benefits... RYGB demonstrating more favorable outcomes for sustained weight loss... Comprehensive meta-analyses of observational studies have predominantly indicated higher rates of T2DM remission with RYGB, as compared to SG
Why this rating
Based on multiple RCTs (SM-BOSS, SLEEVEPASS, STAMPEDE), large meta-analyses, and national registry data.
Source
Bariatric surgery for treatment of morbid obesity in adults
Ki Bum Park et al. · The Korean Journal of Internal Medicine · 2024
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →